Critical Response to Article "Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer"

被引：0
|
作者：
Dany, Frans [1 ]
Nikmah, Uly Alfi [1 ]
Lienggonegoro, Lisa Andriani [1 ]
机构：
[1] Natl Res & Innovat Agcy BRIN, Ctr Biomed Res, Hlth Res Org, Genom Bldg,Jl Raya Bogor 490, Cibinong 16911, West Java, Indonesia
来源：
DRUG DESIGN DEVELOPMENT AND THERAPY | 2023年 / 17卷
关键词：
D O I：
10.2147/DDDT.S417549
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2455 / 2456
页数：2
相关论文
共 50 条
  • [1] Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer
    Zhao, Mei
    Fu, Lijuan
    Xu, Panling
    Wang, Ting
    Li, Ping
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 901 - 917
  • [2] Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer
    Wu, Zhixuan
    Xiang, Haoyi
    Wang, Xiaowu
    Zhang, Rongrong
    Guo, Yangyang
    Qu, Liangchen
    Zhou, Jingyao
    Xiao, Yanyi
    MOLECULAR MEDICINE, 2024, 30 (01)
  • [3] Correction: Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer
    Zhixuan Wu
    Haoyi Xiang
    Xiaowu Wang
    Rongrong Zhang
    Yangyang Guo
    Liangchen Qu
    Jingyao Zhou
    Yanyi Xiao
    Molecular Medicine, 31 (1)
  • [4] Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology
    Wu, Tianhui
    Xiang, Min
    Li, Yujiao
    Gao, Yahan
    Teng, Da
    Sun, Minxuan
    Guo, Weiqiang
    Zhou, Yuanshuai
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12): : 341
  • [5] Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer
    Yang, Xiaojuan
    Li, Feifei
    Shi, Youyang
    Wu, Yuanyuan
    Yang, Rui
    Liu, Xiaofei
    Zhang, Yang
    Zhang, Guangtao
    Ma, Mei
    Luo, Zhanyang
    Han, Xianghui
    Xie, Ying
    Liu, Sheng
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (05): : 763 - 775
  • [6] Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study
    Siddiqui, Arif Jamal
    Elkahoui, Salem
    Alshammari, Ahmed Mohajja
    Patel, Mitesh
    Ghoniem, Ahmed Eisa Mahmoud
    Abdalla, Randa Abdeen Husien
    Dwivedi-Agnihotri, Hemlata
    Badraoui, Riadh
    Adnan, Mohd
    PHARMACEUTICALS, 2025, 18 (03)
  • [7] Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
    Zhang, Yubao
    Ma, Xiaoran
    Li, Huayao
    Zhuang, Jing
    Feng, Fubin
    Liu, Lijuan
    Liu, Cun
    Sun, Changgang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Pharmacological Mechanism of Mume Fructus in the Treatment of Triple-Negative Breast Cancer Based on Network Pharmacology
    Yin, Lei
    Qi, Yan
    Jiang, Yuting
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (11) : 7974 - 7993
  • [9] Network Pharmacology and Experimental Validation to Explore the Potential Mechanism of Nigella sativa for the Treatment of Breast Cancer
    Arif, Rawaba
    Bukhari, Shazia Anwer
    Mustafa, Ghulam
    Ahmed, Sibtain
    Albeshr, Mohammed Fahad
    PHARMACEUTICALS, 2024, 17 (05)
  • [10] Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology
    Chu, Meiling
    Meng, Tian
    Zhou, Yue
    Jin, Lan
    Dai, Qiuying
    Ma, Lina
    Chen, Hongfeng
    MEDICINE, 2023, 102 (35) : E34763
12345